Education and Training:
Dr. Ashish Verma earned his medical degree from Government Stanley Medical College in Chennai, India. He completed his internal medicine residency at the University of Tennessee College of Medicine in Chattanooga, followed by a clinical and research fellowship in nephrology at Brigham and Women’s Hospital and Massachusetts General Hospital. During this time, he also held a joint appointment as a Clinical Fellow in Medicine at Harvard Medical School and trained as a research fellow under Dr. Sushrut S. Waikar, focusing on predictors of CKD progression. His work has been supported by an American Heart Association (AHA) Career Development Award.
Academic Leadership & Editorial Roles:
Dr. Verma is a recognized leader in the global nephrology community, contributing to the field's top-tier academic literature. He serves as an Associate Editor for Kidney360 (American Society of Nephrology portfolio). His professional service and recognition include:
American Heart Association: Member of the Kidney in Cardiovascular Medicine Committee.
Framingham Heart Study: Member of the Ancillary Proposals Review Committee.
National Recognition: Named a Top 1% All-Star Nephrology Researcher (2024–2025) by Avant Garde Health.
Research & Scholarship:
As a clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine, Dr. Verma’s research integrates epidemiology, physiology, and proteomics to uncover pathways of Cardiovascular–Kidney–Metabolic (CKM) disease progression. He has authored more than 70 peer-reviewed publications in premier journals, including BMJ, Annals of Internal Medicine, Circulation, JASN, European Heart Journal, and JACC. His 2025 study on long-term risk estimation across CKM stages was selected for the "Best of ASN Journals."
Clinical Expertise & Mentorship:
Clinically, Dr. Verma specializes in chronic kidney disease, acute kidney injury, cardiorenal syndromes, and systemic amyloidosis. As the Lead Nephrologist for the Boston University Amyloidosis Center, he provides multidisciplinary care for patients with complex systemic diseases at Boston Medical Center.
Deeply committed to medical education, Dr. Verma teaches in BU’s Resident Research Course and mentors medical students, residents, and fellows. Under his guidance, his mentees have consistently achieved first-author publications and received national recognition for their research.
Diversity, Equity, Inclusion and Accessibility
I was born and raised in Hamirpur, a small town in Himachal Pradesh, India, and pursued medical training in Chennai, Tennessee, and Boston. Crossing cultures and health systems has given me a deep appreciation for the value of diversity in medicine and the importance of equity in both patient care and mentorship.
I have cared for patients from underserved communities at the East Boston Neighborhood Health Center, where access, trust, and equity issues are central to daily practice. As lead nephrologist for the Boston University Amyloidosis Center, I see patients from across the United States, bringing a national perspective on the need for inclusive, patient-centered care. These experiences remind me that health equity must be embedded in our research, training, and clinical practice.
As a mentor, I have guided trainees from diverse backgrounds, including first-generation physicians and individuals underrepresented in medicine, supporting their growth through individualized guidance, collaborative scholarship, and opportunities for authorship. My research in cardiovascular–kidney–metabolic health is motivated by the recognition that disparities disproportionately affect marginalized communities, and advancing solutions requires inclusive science and mentorship. Through my clinical care, research, and leadership, I remain committed to amplifying diverse voices and improving equity for patients and the next generation of physicians–scientists.
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
Renal physiology of de-congestion in acute decompensated heart failure07/01/2024 - 06/30/2027 (PI)
American Heart Association/AHA
|
Yr
|
Title
|
Project-Sub Proj
|
Pubs
|
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
-
Thomas P, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of Pancreas Volume With Adverse Clinical Outcomes. J Am Heart Assoc. 2025 Nov 04; 14(21):e042348.View Related Profiles. PMID: 41147404; PMCID: PMC12684549; DOI: 10.1161/JAHA.125.042348;
-
Zheng Q, Shao J, Teng J, Jin J, Abramov D, Verma A, Xu Y, Zhu Q, Yao J, Lv J, Cai F, Huang P, Zhou H, Zhou J. Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3. JACC Adv. 2025 Oct 21; 102274. PMID: 41165649; DOI: 10.1016/j.jacadv.2025.102274;
-
Schmidt IM, Verma A, Claudel S, Rosan S, Lu W, Beck LH, Huynh C, Palsson R, Srivastava A, Stillman I, Avillach C, Huber TB, Volpe J, Betanzos CM, Ocana MF, Berasi SP, Fader KA, Hassanein M, Waikar SS. Associations of Podocyte-Derived Protein Biomarkers With Foot Process Effacement and Kidney Histopathologic Lesions in Individuals With Glomerular Disease. Kidney Med. 2025 Dec; 7(12):101144.View Related Profiles. PMID: 41342046; PMCID: PMC12671356; DOI: 10.1016/j.xkme.2025.101144;
-
Thomas P, Salud M, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, Schmidt IM, van Raalte DH, Bjornstad P, Layden BT, Lash JP, Waikar SS, Srivastava A. Association of pancreas fat fraction with adverse kidney and cardiovascular outcomes. Clin Kidney J. 2025 Dec; 18(12):sfaf310. PMID: 41404372; PMCID: PMC12703370; DOI: 10.1093/ckj/sfaf310;
-
-
Wittig M, Verma A, Bellavia A, Rosan S, Claudel SE, Surapaneni A, Palsson R, Srivastava A, Stillman IE, Henderson JM, Beck LH, Hodgin JB, Grams ME, Rhee EP, Huber TB, Waikar SS, Schmidt IM. The Associations of Foot Process Effacement with Kidney Histopathologic Lesions and Disease Progression. Kidney360. 2025 Jul 29.View Related Profiles. PMID: 40728890; DOI: 10.34067/KID.0000000894;
-
-
Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Correction: Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 May 14; 26(1):239. PMID: 40369429; PMCID: PMC12080121; DOI: 10.1186/s12882-025-04151-x;
-
Showing 10 of 78 results.
Show More
-
-
Kar D, Byng R, Sheikh A, Nath M, Zabeen B, Kar S, Banu S, Sarker MHR, Khan N, Acharjee D, Islam S, Allgar V, Ordóñez-Mena JM, El-Wazir A, Song S, Verma A, Kadam U, de Lusignan S. Navigating the complexities of end-stage kidney disease (ESKD) from risk factors to outcome: insights from the UK Biobank cohort. BMC Nephrol. 2025 Apr 01; 26(1):168. PMID: 40169952; PMCID: PMC11959863; DOI: 10.1186/s12882-025-04090-7;
-
-
-
-
-
Agarwal R, Verma A, Georgianos PI. Diuretics in patients with chronic kidney disease. Nat Rev Nephrol. 2025 Apr; 21(4):264-278. PMID: 39775051; DOI: 10.1038/s41581-024-00918-x;
-
Schmidt IM, Kefalogianni E, Zhao R, Verma A, Sabbisetti V, Rahman M, Pradhan N, Srivastava A, He J, Chen J, Waikar SS, Herrlich A. Associations of Serum Amphiregulin Levels With Kidney Failure and Mortality: The Chronic Renal Insufficiency Cohort (CRIC). Kidney Med. 2025 Mar; 7(3):100958.View Related Profiles. PMID: 40071064; PMCID: PMC11894294; DOI: 10.1016/j.xkme.2024.100958;
-
-
-
Claudel SE, Waikar SS, Schmidt IM, Vasan RS, Verma A. The relationship between low levels of albuminuria and mortality among adults without major cardiovascular risk factors. Eur J Prev Cardiol. 2024 Dec 04; 31(17):2046-2055.View Related Profiles. PMID: 38825979; PMCID: PMC11629963; DOI: 10.1093/eurjpc/zwae189;
-
-
Anand SK, Staron A, Mendelson LM, Joshi T, Burke N, Sanchorawala V, Verma A. Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease. Am J Hematol. 2024 Nov; 99(11):2140-2151.View Related Profiles. PMID: 39257247; DOI: 10.1002/ajh.27472;
-
Schmidt IM, Surapaneni AL, Zhao R, Upadhyay D, Yeo WJ, Schlosser P, Huynh C, Srivastava A, Palsson R, Kim T, Stillman IE, Barwinska D, Barasch J, Eadon MT, El-Achkar TM, Henderson J, Moledina DG, Rosas SE, Claudel SE, Verma A, Wen Y, Lindenmayer M, Huber TB, Parikh SV, Shapiro JP, Rovin BH, Stanaway IB, Sathe NA, Bhatraju PK, Coresh J, Rhee EP, Grams ME, Waikar SS. Plasma proteomics of acute tubular injury. Nat Commun. 2024 Aug 27; 15(1):7368.View Related Profiles. PMID: 39191768; PMCID: PMC11349760; DOI: 10.1038/s41467-024-51304-x;
-
Chugh PV, Danford J, Farber A, Ayalon N, Verma A, Helm RH, Monahan KM, Kalish JA. Retrieval of Embolized WATCHMAN® Flex Atrial Appendage Occlusion Device. Vasc Endovascular Surg. 2024 Oct; 58(7):752-756.View Related Profiles. PMID: 38747057; DOI: 10.1177/15385744241251657;
-
Verma A, Schmidt IM, Claudel S, Palsson R, Waikar SS, Srivastava A. Association of Albuminuria With Chronic Kidney Disease Progression in Persons With Chronic Kidney Disease and Normoalbuminuria : A Cohort Study. Ann Intern Med. 2024 Apr; 177(4):467-475.View Related Profiles. PMID: 38560911; PMCID: PMC12124184; DOI: 10.7326/M23-2814;
-
-
-
-
-
-
-
Srivastava A, Amodu A, Liu J, Verma A, Mothi SS, Palsson R, Stillman IE, Kestenbaum BR, Waikar SS. The Associations of Urine Albumin-Protein Ratio With Histopathologic Lesions and Clinicopathologic Diagnoses in Individuals With Kidney Disease. Am J Kidney Dis. 2024 Apr; 83(4):557-560.View Related Profiles. PMID: 37827424; PMCID: PMC12558413; DOI: 10.1053/j.ajkd.2023.08.012;
-
Shankara Anand; Ashish Verma . Artificial Intelligence in Clinical Practice:
How AI Technologies Impact Medical Research and Clinics. Artificial intelligence in nephrology. Academic Press; Elsevier. 2023; 201-209. View Publication
-
Ferkowicz MJ, Verma A, Barwinska D, Melo Ferreira R, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):266-275.View Related Profiles. PMID: 37533147; PMCID: PMC10861111; DOI: 10.2215/CJN.0000000000000276;
-
-
-
-
Buckley LF, Schmidt IM, Verma A, Palsson R, Adam D, Shah AM, Srivastava A, Waikar SS. Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease. JAMA Cardiol. 2023 Apr 01; 8(4):357-365.View Related Profiles. PMID: 36884237; PMCID: PMC9996453; DOI: 10.1001/jamacardio.2023.0056;
-
-
-
-
-
Schmidt IM, Myrick S, Liu J, Verma A, Srivastava A, Palsson R, Onul IF, Stillman IE, Avillach C, Patil P, Waikar SS. The use of plasma biomarker-derived clusters for clinicopathologic phenotyping: results from the Boston Kidney Biopsy Cohort. Clin Kidney J. 2023 Jan; 16(1):90-99.View Related Profiles. PMID: 36726432; PMCID: PMC9871860; DOI: 10.1093/ckj/sfac202;
-
Ilori TO, Liu J, Rodan AR, Verma A, Mills KT, He J, Winkler CA, Dupuis J, Anderson CAM, Waikar SS. Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression. Clin J Am Soc Nephrol. 2022 Oct; 17(10):1477-1486.View Related Profiles. PMID: 36400568; PMCID: PMC9528272; DOI: 10.2215/CJN.02680322;
-
Ujjawal A, Schreiber B, Verma A. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence? Ther Adv Endocrinol Metab. 2022; 13:20420188221090001. PMID: 35450095; PMCID: PMC9016587; DOI: 10.1177/20420188221090001;
-
-
Albuquerque AM, Santolia CB, Verma A. Concerns about the interpretation of subgroup analysis. J Clin Invest. 2022 01 18; 132(2). PMID: 34855622; PMCID: PMC8759777; DOI: 10.1172/JCI155991;
-
Subudhi S, Voutouri C, Hardin CC, Nikmaneshi MR, Patel AB, Verma A, Khandekar MJ, Dutta S, Stylianopoulos T, Jain RK, Munn LL. Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling. EBioMedicine. 2022 Jan; 75:103809. PMID: 35033853; PMCID: PMC8757652; DOI: 10.1016/j.ebiom.2021.103809;
-
Liu J, Tio MC, Verma A, Schmidt IM, Ilori TO, Knauf F, Mc Causland FR, Waikar SS. Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease. J Clin Endocrinol Metab. 2022 01 01; 107(1):e281-e292.View Related Profiles. PMID: 34390334; PMCID: PMC8684460; DOI: 10.1210/clinem/dgab574;
-
Leung G, Verma A. Epidemiological Study of COVID-19 Fatalities and Vaccine Uptake: Insight From a Public Health Database in Ontario, Canada. Cureus. 2021 Jul; 13(7):e16160. PMID: 34367770; PMCID: PMC8330391; DOI: 10.7759/cureus.16160;
-
-
Subudhi S, Verma A, Patel AB, Hardin CC, Khandekar MJ, Lee H, McEvoy D, Stylianopoulos T, Munn LL, Dutta S, Jain RK. Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19. NPJ Digit Med. 2021 May 21; 4(1):87. PMID: 34021235; PMCID: PMC8140139; DOI: 10.1038/s41746-021-00456-x;
-
Patel AB, Mistry K, Verma A. DAPA-CKD: Significant Victory for CKD with or without Diabetes. Trends Endocrinol Metab. 2021 06; 32(6):335-337. PMID: 33676827
-
Verma A, Patel AB. Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease. Trends Endocrinol Metab. 2021 05; 32(5):261-263. PMID: 33637415
-
Voutouri C, Nikmaneshi MR, Hardin CC, Patel AB, Verma A, Khandekar MJ, Dutta S, Stylianopoulos T, Munn LL, Jain RK. In silico dynamics of COVID-19 phenotypes for optimizing clinical management. Proc Natl Acad Sci U S A. 2021 01 19; 118(3). PMID: 33402434; PMCID: PMC7826337; DOI: 10.1073/pnas.2021642118;
-
Patel AB, Verma A. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2? Clin Infect Dis. 2020 11 19; 71(16):2129-2131. PMID: 32442259; PMCID: PMC7314195; DOI: 10.1093/cid/ciaa627;
-
-
-
Subudhi S, Verma A, Patel AB. Prognostic machine learning models for COVID-19 to facilitate decision making. Int J Clin Pract. 2020 Dec; 74(12):e13685. PMID: 32810316; PMCID: PMC7461008; DOI: 10.1111/ijcp.13685;
-
Verma A, Patel AB, McMahon GM. The Case | Hyponatremia with an increased osmolar gap. Kidney Int. 2020 09; 98(3):797-798. PMID: 32828247
-
Verma A, Qayyum R. Non-lactate strong ion difference and cardiovascular, cancer and all-cause mortality. Clin Chem Lab Med. 2020 08 27; 59(2):403-409. PMID: 32853162
-
Patel AB, Verma A, McMahon GM. Nephrolithiasis from an Unexpected Cause: Phosphaturia. Am J Med. 2021 02; 134(2):e131-e132. PMID: 32858021
-
Schreiber B, Patel A, Verma A. Shedding Light on COVID-19: ADAM17 the Missing Link? Am J Ther. 2020 Aug 03; 28(3):e358-e360. PMID: 32769398
-
Verma A, Patel AB, Waikar SS. SGLT2 Inhibitor: Not a Traditional Diuretic for Heart Failure. Cell Metab. 2020 07 07; 32(1):13-14.View Related Profiles. PMID: 32640243
-
-
Patel AB, Verma A. Nasal ACE2 Levels and COVID-19 in Children. JAMA. 2020 06 16; 323(23):2386-2387. PMID: 32432681
-
Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA. 2020 May 12; 323(18):1769-1770. PMID: 32208485
-
Verma A, Patel AB, Upadhyay A, Waikar SS. CREDENCE: Significant Victory for Diabetic Kidney Disease. Trends Endocrinol Metab. 2020 06; 31(6):391-393.View Related Profiles. PMID: 32327275
-
-
Verma A, Shahid MH, Youngblood L. Lesson Learned Through a Case of Pneumococcal Meningitis: Sometimes Doing Less Is More Harmful. Am J Med. 2018 10; 131(10):e409-e410. PMID: 29928862; DOI: 10.1016/j.amjmed.2018.05.032;
-
-
Verma A, Shahid MH, Boldt JW. Gastric perforation following cardiopulmonary resuscitation. Intensive Care Med. 2018 Oct; 44(10):1752-1753. PMID: 29789860; DOI: 10.1007/s00134-018-5178-9;
-
Shahid MH, Verma A, Youngblood L. From Mechanical to Chemical: A Case of Diabetes Insipidus Induced by Concussive Brain Injury. Am J Med. 2018 07; 131(7):e293-e294. PMID: 29596786; DOI: 10.1016/j.amjmed.2018.02.027;
-
Ban BH, Verma A, Tudor M, Sethi J. Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura. Oxf Med Case Reports. 2017 Jun; 2017(6):omx026. PMID: 28580158; PMCID: PMC5451891; DOI: 10.1093/omcr/omx026;
-
Roy-Chaudhury P, Verma A. Improving patient safety in vascular access: a role for individualization and patient preferences. Contrib Nephrol. 2015; 184:136-42. PMID: 25676298; DOI: 10.1159/000367680;
-
Ganesh G, Shankaranarayanan D, Verma A, Thirumurthi K, Mathew M, Abraham G. Unusual presentation of a common disease in an ESRD patient. Kidney Int. 2013 Nov; 84(5):1055. PMID: 24172748; DOI: 10.1038/ki.2013.155;
-
Shankaranarayanan D, Verma A, Yuvaraj A, Abraham G, Kurien A. Late occurrence of an unusual tumour of left native kidney in an allograft recipient. Clin Kidney J. 2013 Aug; 6(4):443-4. PMID: 27293577; PMCID: PMC4898333; DOI: 10.1093/ckj/sft054;
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
| Year | Publications |
|---|
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 13 |
| 2021 | 6 |
| 2022 | 10 |
| 2023 | 13 |
| 2024 | 10 |
| 2025 | 17 |
2026 American Society of Nephrology:
Associate Editor Kidney360 Journal
2025 Avant-Garde Health:
Top 1% Nephrology Researcher All-Star
2025 American Society of Nephrology:
Best of ASN Journals (2025), recognizing top publications of the year in JASN
2025 Sigma Xi:
Member of Sigma Xi (The Scientific Research Honor Society)
2024 American Heart Association :
Career Development Award
2024 Annals of Internal Medicine :
Best reviewer
2024 Department of Medicine, BUCAMS:
DOM Investment Award
2023 Nephrology Dialysis Transplantation(NDT) Journal:
Editorial Fellow
2021 American Society of Nephrology:
Fellow of American Society of Nephrology
2019 Brigham and Women's Hospital:
Fellowship Teaching Award, Department of Medicine
2019 American Society of Nephrology:
Fellowship in Training Bowl Champion
2018 University of Tennessee College of Medicine, Chattanooga:
Best Resident Research Award
2018 University of Tennessee College of Medicine, Chattanooga:
Academic Honors
2017 American College of Physicians:
Internal medicine Jeopardy Champion-Tennesse State